Once for Life

Once for Life

Creating transformational gene and peptide therapies that treat the most prevalent diseases to restore health and renew life


Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site

 

Latest News:  April 11, 2017: 'Human Gene Therapy' publishes review of randomized clinical trials of gene transfer for heart failure with reduced ejection fraction

  March 7, 2017: UNIAPAC FOUNDATION THINK TANK IN PARIS SELECTS RENOVA THERAPEUTICS CEO AND CO-FOUNDER AS KEYNOTE SPEAKER FOR ANNUAL MEETING

View All News
Subscribe to receive company press releases and announcements
*required